Introduction AMP/ANESA/DAD-ANI MODEL-19 is a non-invasive screening device with global recognition for its diagnostics and preventive screening capabilities. The device has been used by medical professionals for help with setting diagnosis or to determine the need of further testing, therefore reducing unnecessary expenses and increasing the value of their services. As of June 2020, AMP/ANESA/DAD-ANI MODEL-19 has been re-certified in Europe for CE by TUV NORD by Biopromin company, led by Mr Anatolii Pulavskyi. Due to the company’s 20-year experience on the market, the company has made certain changes to add more value to medical professionals.
New design: The new surface of the design is compact and strong. The box has successfully passed technical trials and all safety procedures.
Addition of features: The product also now has built it Bluetooth, which means that it can be connected to any computer, laptop, and windows-based tablet remotely.
Parameters and identifiable pathologies: The company has made more focus on the predictive algorithms to help medical professionals make constructive decisions. To simplify the practical usage of the device, the company has shifted majority of “derived” parameters to identification of health risks and pathologies. This way, a medical professional will get notifications when these parameters are out of normal ranges and require further investigation.
New list of health risks and pathologies:
|
CBC (Hemogram): Hemoglobin HGB. g/l Erythrocytes RBC. x10¹²/l Leukocytes WBC. x10⁹/l Segmented neutrophiles. NEUT % Band neutrophiles. NEUT % Lymphocytes. LYMPH % Monocytes.MONO % Eosinophils. % Erythrocyte sedimentation rate ESR. mm/h |
|
Blood Coagulation: Hematocrit.HCT % Thrombocytes. x10⁹/l Carbohydrate metabolism: Glucose. mmol/l Electrolyte metabolism: Calcium (Ca). mmol/l Magnesium (Mg). mmol/l Potassium (K). mmol/l Sodium (Na). mmol/l |
|
Protein metabolism: Creatinine. μmol/l Urea. mmol/l Lipid Metabolism: Cholesterol total. mmol/l Triglycerides (TG). mmol/l Low-density lipoproteins (LDL). mmol/l High-density lipoproteins (HDL). mmol/l Enzymes: Amylase (W.Т.Caraway). g/l*h Renal panel: Ceruloplasmin (CP). g/l |
|
Hepatic Panel: Aspartate transaminase (AST). mmol/l Alanine transaminase (ALT). E/l Aspartate transaminase (AST). mmol/l Alanine transaminase (ALT). E/l Protein, Total. g/l Bilirubin, Total. μmol/l Bilirubin, Direct. μmol/l Blood coagulation: Beginning of clotting (method of Lee-White). Min End of clotting (method of Lee-White). Min |
List of parameters shown as above/below defined norm.:
|
Cell mitosis regulation: Comprehensive cell mitosis regulation factor. Protein metabolism: Dopamine β-hydroxylase (DBH). nmol/ml/min. Internal blood flow, in % to total blood flow: Myocardial blood flow. % Muscular blood flow. % Cerebral blood flow. % Hepatoportal blood flow. % Nephritic blood flow. % Skin blood flow. % Blood flow of other organs. % |
|
Functional parameters of stomach: pH of gastric juice. SH. Basal pressure of Oddi’s sphincter mm Hg Transport and elimination of CO₂: CO₂ elimination. ml/min (CO₂) in arterial blood. % (CO₂) venous blood. % Rate of CO₂ production. ml/min Other: Atherogenic index of plasma (AIP) TIMI idex Colloid-Oncotic pressure Mean arterial pressure |
|
Functional parameters of cardio-respiratory system: Vital capacity of lungs (VC). cm³. Minute ventilation (VE) l/min Peak expiratory flow (PEF). l/min Test Tiffeneau. % Working rate of oxygen consumption. % Time of single load. min Respiratory exchange ratio (RER). |
|
Oxygen transport and consumption: Transportation of oxygen(O₂). ml/min Quantity of assimilated oxygen on 100 gr. of cerebral tissue. Ml Oxygen saturation in arterial blood (SaO₂). % Oxygen consumption per kg of body weight. ml/min/kg O₂ consumption.(VO₂) ml/min Myocardial oxygen consumption. ml/min |